Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 2003 Oct 2;42(2):242–245. doi: 10.1046/j.1365-2125.1996.39817.x

Clonidine and or adrenaline decrease lignocaine plasma peak concentration after epidural injection

JEAN XAVIER MAZOIT 1,2, DAN BENHAMOU 1,3, YVES VEILLETTE 3, KAMRAN SAMII 1,2
PMCID: PMC2042658  PMID: 8864326

Abstract

Clonidine is an α2-adrenoceptor agonist increasingly used in combination with lignocaine for spinal or epidural anaesthesia because of a prolonged analgesic effect. Like adrenaline, it may decrease lignocaine peak concentration (Cmax), thus leading to decreased toxicity. However, the effects of clonidine on resorption of lignocaine into the systemic circulation from the epidural space remain to be established. We studied the pharmacokinetics of lignocaine after epidural injection of lignocaine with or without clonidine, adrenaline and both drugs. Total body clearance and apparent volume of distribution were similar in the four groups, but the maximum observed concentration (Cmax) was markedly increased in the plain solution group as compared with the other groups: (plain lignocaine: 7.15±2.04 μg ml−1, lignocaine+adrenaline: 3.11±136 μg ml−1, lignocaine+clonidine: 4.48±1.26 μg ml−1, lignocaine+adrenaline+clonidine: 4.06±1.42 μg ml−1 [mean±s.d.]). Our results show that, clonidine decreases lignocaine Cmax to the same extent as adrenaline.

Keywords: local anaesthetics, lignocaine, epidural anaesthesia, clonidine, peak concentration, pharmacokinetics, regional anaesthesia

Full Text

The Full Text of this article is available as a PDF (225.2 KB).


Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES